Mevlüde İnanç

666 total citations
35 papers, 481 citations indexed

About

Mevlüde İnanç is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mevlüde İnanç has authored 35 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Mevlüde İnanç's work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Treatment and Pharmacology (6 papers). Mevlüde İnanç is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Treatment and Pharmacology (6 papers). Mevlüde İnanç collaborates with scholars based in Türkiye and United Kingdom. Mevlüde İnanç's co-authors include Velı Berk, Oktay Bozkurt, Halıt Karaca, Metin Özkan, Ersin Özaslan, Ali Doğan, Nihat Kalay, Cevat Yazıcı, Mahmut Akpek and Ali Ergin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of the Rheumatic Diseases.

In The Last Decade

Mevlüde İnanç

32 papers receiving 475 citations

Peers

Countries citing papers authored by Mevlüde İnanç

Since Specialization

Citations

This map shows the geographic impact of Mevlüde İnanç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mevlüde İnanç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mevlüde İnanç more than expected).

Fields of papers citing papers by Mevlüde İnanç

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mevlüde İnanç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mevlüde İnanç. The network helps show where Mevlüde İnanç may publish in the future.

Co-authorship network of co-authors of Mevlüde İnanç

This figure shows the co-authorship network connecting the top 25 collaborators of Mevlüde İnanç. A scholar is included among the top collaborators of Mevlüde İnanç based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mevlüde İnanç. Mevlüde İnanç is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	miR-484 as an “OncomiR” in Breast Cancer Promotes Tumorigenesis by Suppressing Apoptosis Genes 2024 ·Annals of Surgical Oncology ·(unknown), Zühal Hamurcu, (unknown), (unknown), (unknown), (unknown), (unknown), Mevlüde İnanç, Elif Funda Şener	3
2	Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non–Small-Cell Lung Cancer 2023 ·Clinical Lung Cancer ·Ayşe Ocak Duran, Mevlüde İnanç, Oktay Bozkurt, Ersin Özaslan, Metin Özkan	4
3	Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer 2020 ·Journal of Turkish Society of Obstetric and Gynecology ·Özlem Erçelep, (unknown), Melike Özçelik, (unknown), (unknown), Mevlüde İnanç, Mehmet Aliustaoğlu, Mahmut Gümüş	1
4	Biweekly cisplatin and gemcitabine with two different doses in non small cell lung cancer patients: A retrospective singlecenter experience. 2019 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Oktay Bozkurt, Mevlüde İnanç, Metin Özkan	1
5	The relationship between plasma hyaluronan levels and anthracycline-related cardiotoxicity in breast cancer patients 2016 ·International Journal of Cardiology ·Mehmet Tuğrul İnanç, (unknown), Metin Aytekin, Ayşe Ocak Duran, (unknown), Mahmut Akpek, Ömer Şahin, Nihat Kalay, Halıt Karaca, Metin Özkan, Mevlüde İnanç	2
6	Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients? 2015 ·Journal of Chemotherapy ·Oktay Bozkurt, Halıt Karaca, İlhan Hacıbekiroğlu, Kaplan Ma, (unknown), Mükremın Uysal, Velı Berk, Mevlüde İnanç, Ayşe Ocak Duran, Ersin Özaslan, (unknown), Metin Özkan	14
7	Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients? 2015 ·Clinical Genitourinary Cancer ·Oktay Bozkurt, İlhan Hacıbekiroğlu, Kaplan Ma, (unknown), Mükremın Uysal, Halıt Karaca, Velı Berk, Mevlüde İnanç, Ayşe Ocak Duran, Ersin Özaslan, (unknown), Metin Özkan	7
8	Medication Errors in Chemotherapy Preparation and Administration: a Survey Conducted among Oncology Nurses in Turkey 2015 ·Asian Pacific Journal of Cancer Prevention ·Arife Ulaş, Kamile Sılay, (unknown), Didem Şener Dede, Muhammed Bülent Akıncı, Mehmet Alı Nahıt Şendur, Erdem Çubukçu, Hasan Şenol Çoşkun, (unknown), Güngör Utkan, Nuriye Özdemir, Abdurrahman Işıkdoğan, Abdullah Büyükçelik, Mevlüde İnanç, Ahmet Bılıcı, (unknown), Şener Cihan, Nilüfer Avcı, Bülent Yalçın	34
9	Predictive Significance of VEGF and HIF-1α Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizumab 2015 ·Asian Pacific Journal of Cancer Prevention ·Velı Berk, Kemal Denız, Oktay Bozkurt, Ersin Özaslan, (unknown), Mevlüde İnanç, Ayşe Ocak Duran, Metin Özkan	14
10	Lack of Prognostic Value of Mean Corpuscular Volume with Capecitabine Therapy in Metastatic Breast Cancer 2014 ·Asian Pacific Journal of Cancer Prevention ·Oktay Bozkurt, Velı Berk, Kaplan Ma, Bülent Çetin, Ersin Özaslan, (unknown), Mevlüde İnanç, Ayşe Ocak Duran, Metin Özkan	5
11	Haematologic Parameters in Metastatic Colorectal Cancer Patients Treated with Capecitabine Combination Therapy 2014 ·Asian Pacific Journal of Cancer Prevention ·Mevlüde İnanç, Ayşe Ocak Duran, (unknown), Velı Berk, Oktay Bozkurt, Ersin Özaslan, Metin Özkan	14
12	Albumin-globulin Ratio for Prediction of Long-term Mortality in Lung Adenocarcinoma Patients 2014 ·Asian Pacific Journal of Cancer Prevention ·Ayşe Ocak Duran, Mevlüde İnanç, (unknown), (unknown), Velı Berk, Oktay Bozkurt, Ersin Özaslan, (unknown), Celalettin Eroğlu, Metin Özkan	54
13	Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy 2014 ·European Journal of Heart Failure ·Mahmut Akpek, İbrahіm Özdoğru, Ömer Şahin, Mevlüde İnanç, Ali Doğan, Cevat Yazıcı, Velı Berk, Halıt Karaca, Nihat Kalay, Abdurrahman Oğuzhan, Ali Ergin	162
14	Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology 2013 ·Asian Pacific Journal of Cancer Prevention ·(unknown), (unknown), S. Seber, Mehmet Küçüköner, (unknown), Özlem Sönmez, (unknown), Tülay Akman, Bilge Aktaş, Ramazan Yıldız, (unknown), Mevlüde İnanç, Umut Demırcı, Necati Alkış, Mahmut Gümüş	8
15	Clinical and Pathologic Features of Patients with Rare Ovarian Tumors: Multi-Center Review of 167 Patients by the Anatolian Society of Medical Oncology 2013 ·Asian Pacific Journal of Cancer Prevention ·Ahmet Bılıcı, Mevlüde İnanç, Arife Ulaş, Tülay Akman, Mesut Şeker, Nalan Akgül Babacan, Ali̇ İnal, Öznur Bal, (unknown), Alper Sevinç, (unknown), Emin Tamer Elkıran, Bala Başak Öven Ustaalıoğlu, Tuğba Yavuzşen, Necati Alkış, Metin Özkan, Mahmut Gümüş	11
16	Acute Pericarditis On 5-Fluorouracil, Docetaxel And Cisplatin Therapy 2012 ·Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology ·Mevlüde İnanç, Mahmut Akpek, Mehmet Tuğrul İnanç, Mehmet Güngör Kaya	2
17	Prognostic Analysis of Patients with Operable Gastric Cancer and Tolerability to Adjuvant Radio-Chemo-Therapy 2012 ·Neoplasma ·(unknown), (unknown), Abdurrahman Işıkdoğan, Mehmet Bilici, Doğan Uncu, Bülent Çetin, (unknown), Mevlüde İnanç, (unknown), Ali̇ İnal, (unknown), (unknown), Nuriye Özdemir, Kaplan Ma, Sercan Aksoy, Necati Alkış, Salim Başol Tekin, Celalettin Eroğlu, Serdar Turhal, (unknown)	3
18	Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer 2012 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Uğur Çoşkun, (unknown), Mevlüde İnanç, (unknown), Berna Öksüzoğlu, Nuriye Özdemir, (unknown), Mustafa Beneklı, Aytuğ Üner, Deniz Yamaç, Umut Demırcı, Ramazan Yıldız, Halıt Karaca, Olçun Ümit Ünal, Öznur Bal, Mahmut Gümüş, Süleyman Buyukberber	12
19	Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer 2012 ·Asian Pacific Journal of Cancer Prevention ·Meltem Baykara, Uğur Çoşkun, Velı Berk, Metin Özkan, Kaplan Ma, Mustafa Beneklı, Halıt Karaca, Mevlüde İnanç, Abdurrahman Işıkdoğan, Alper Sevinç, Emin Tamer Elkıran, Umut Demırcı, Süleyman Buyukberber	4
20	Prognostic Factors and Treatment Outcomes in 93 Patients with Uterine Sarcoma from 4 Centers in Turkey 2012 ·Asian Pacific Journal of Cancer Prevention ·Ayşe Durnalı, (unknown), Nuriye Özdemir, Mevlüde İnanç, (unknown), Nurullah Zengin, Osman Sönmez, Mehmet Küçüköner	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact